A groundbreaking medical achievement has emerged from China, stirring hope and cautious optimism in the world of organ transplantation.

In a bold experiment, scientists have successfully transplanted a genetically modified pig liver into a human recipient, paving the way for potential life-saving solutions to the persistent shortage of donor organs. The study, which has sent ripples through the medical community, demonstrated that a pig liver could function effectively inside a human body for a short period without triggering severe immune rejection or inflammation.

The liver is an extraordinary organ. It possesses unparalleled regenerative powers, but it is also subjected to constant wear and tear. Over time, this vital organ can accumulate scars, leading to liver failure—a condition that leaves patients with only one viable option: a transplant. However, the grim reality is that donor livers are notoriously scarce. Thousands of patients languish on waitlists globally, and many succumb before a suitable organ becomes available. The new research offers a glimmer of hope by exploring an unconventional but promising solution—xenotransplantation, or the transplantation of organs between different species.

The Chinese team behind this pioneering work employed cutting-edge gene-editing technologies to modify a pig liver and make it more compatible with the human body. The genetic modifications targeted several critical areas. They eliminated genes responsible for triggering hyperacute immune rejection—an immediate and aggressive response by the immune system to foreign tissue. Additionally, genes were added to make the organ appear more “human-like” to the recipient’s immune system.

The experiment involved transplanting the genetically engineered liver from a Bama miniature pig—a breed known for its organ size compatibility with humans—into a brain-dead middle-aged man. Notably, the recipient’s own liver was still functional, as the goal of the study was not to replace it but to evaluate how well the pig liver could perform its natural functions in a human body. Within just two hours of transplantation, the pig liver began producing bile, an essential digestive fluid that breaks down fats. Over the next 10 days, it continued functioning, synthesising albumin (a crucial protein) and maintaining smooth blood flow without significant complications.

This achievement marks an important milestone in liver xenotransplantation, but experts urge caution. While the results are promising, many questions remain unanswered. The study primarily focused on bile production and albumin synthesis but did not assess other critical liver functions, such as toxin filtration or drug metabolism. Furthermore, since the recipient’s own liver was still operational, it is unclear whether the pig liver would be capable of sustaining life in a patient with complete liver failure.

The broader context of xenotransplantation underscores its immense potential and challenges. There is an acute global shortage of donor organs. For many, this wait can stretch into months or even years—time they do not have. Xenotransplantation offers a potential lifeline by tapping into animal organs as a resource. Among various species considered, pigs have emerged as particularly promising candidates due to their physiological similarities with humans and their relatively short gestation periods.

However, pig organs are not inherently compatible with human bodies. They are covered in sugars that can trigger severe immune responses upon transplantation. Moreover, pigs carry porcine endogenous retroviruses (PERVs) embedded in their DNA. While harmless to pigs, these viruses pose a theoretical risk of infecting human cells and causing disease. To address these challenges, scientists have employed advanced gene-editing tools to modify pig organs extensively. In recent years, genetically engineered pig hearts and kidneys have been transplanted into non-human primates and even some human recipients with varying degrees of success.

The journey towards successful xenotransplantation has been marked by incremental progress. In 2021, researchers transplanted a genetically modified pig kidney into a brain-dead individual. The organ was attached externally to blood vessels in the leg and functioned without immediate rejection. Subsequent experiments have included pig heart transplants into living patients, though outcomes have been mixed. While one patient tragically passed away shortly after receiving a pig heart, another recipient of a pig kidney experienced a remarkable recovery and was able to return home.

Liver xenotransplants present unique challenges. The liver is an exceptionally complex organ that performs a wide array of functions—metabolising drugs and toxins, producing bile and proteins for blood clotting, and regulating chemical levels in the blood. Each of these tasks relies on intricate molecular processes that may differ significantly between pigs and humans. A mismatch in these processes could render a transplanted pig liver non-functional or provoke dangerous immune reactions.

In 2023, researchers in the United States took an initial step towards addressing these challenges by connecting a genetically engineered pig liver to the bloodstream of a brain-dead individual. The liver remained functional for at least 72 hours outside the body, demonstrating its potential viability. Building on this work, the recent Chinese study extended the duration of observation to 10 days and tested the organ inside the recipient’s body.

Despite its success, the experiment raises important ethical and scientific considerations. The use of brain-dead individuals as research subjects allows scientists to test novel treatments without risking harm to living patients. However, this approach limits the scope of conclusions that can be drawn about long-term outcomes or the effectiveness of xenotransplants in patients with severe organ failure.

The researchers behind the study envision pig livers as temporary “bridge” transplants rather than permanent solutions. In cases where patients suffer acute liver failure and are at risk of death while waiting for a human donor organ, a genetically modified pig liver could provide vital support for days or weeks. This temporary measure could stabilise patients, giving them precious time until a suitable human organ becomes available or their own liver recovers.

Encouraged by their initial success, the research team has already completed a full pig-to-human liver transplant, replacing the entire liver of another brain-dead individual with one from a genetically modified pig. Details of this experiment are expected to be released in an upcoming publication.

While these advancements are undoubtedly impressive, much work remains before xenotransplantation can become a routine clinical practice. Scientists must address several lingering questions: Can pig livers reliably perform all necessary functions in human bodies? How long can they sustain life without complications? What are the long-term risks associated with using animal organs, particularly concerning viral transmission?

For now, this landmark study represents a significant leap forward in the quest to overcome organ shortages. It demonstrates not only the feasibility of using gene-edited animal organs but also highlights the remarkable resilience of science in tackling seemingly insurmountable challenges. As researchers continue to refine these techniques and test their safety and efficacy, the dream of saving countless lives through xenotransplantation edges closer to reality.